This Solicitation opportunity from Department Of Defense was posted on September 8, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

GUAIFENESIN AND DEX

Closed

SPE2DP-26-T-4947Federal

Submission Closed09/14/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

HYDROXYPROPYL METHYLCE

Solicitation # SPE2DP-27-T-0185

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0186

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing and SupplyThis subcontract for Pharmaceutical Manufacturing and Supply involves the production and delivery of specialized pharmaceutical preparations for prime contractors supporting the Department of Veterans Affairs. The scope of work encompasses the entire manufacturing lifecycle, including the compounding of pharmaceuticals, rigorous quality control testing, packaging, and labeling, with final delivery to VA facilities. To qualify, providers must maintain pharmaceutical grade manufacturing facilities and clean rooms, ensuring full FDA approval and strict adherence to current Good Manufacturing Practice compliance. This opportunity is managed under the Department of Veterans Affairs Network Contract Office 22 and is categorized under NAICS code 325412.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

6505--VA Long Beach Pylarify

Solicitation # 36C26227Q0072

The Department of Veterans Affairs Long Beach Healthcare System intends to award a sole source, firm-fixed-price delivery order for Pylarify (piflufolastat F18) radiopharmaceutical injections. This advanced diagnostic imaging agent is utilized by the Nuclear Medicine department in conjunction with PET/CT scans to identify prostate-specific membrane antigen (PSMA) in prostate tumors, lymph nodes, bones, and other organs. The procurement is categorized under NAICS code 325412, Pharmaceutical Preparation Manufacturing, which has a size standard of 1,300 employees. The government has identified Progenics Pharmaceuticals, Inc. as the intended contractor, as the product is available under the VA National Acquisition Center Contract Federal Supply Schedule 36F79725D0093, effective from April 1, 2025, through March 31, 2030. This action is being conducted in accordance with RFO Part 8.401 and GSAM/R 538.7104-3(b)(ii) and 538.7104-4 regarding items peculiar to one manufacturer. While this is not a formal solicitation, interested parties capable of providing the same items may submit a capabilities statement to Contracting Specialist Melissa Ramirez by November 3, 2026, at 10:00 AM Pacific Local Time.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

POVIDONE-IODINE CLEANS

Solicitation # SPE2DP-27-T-0181

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0182

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

PERMETHRIN CREAM RINSE

Solicitation # SPE2DP-27-T-0180

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Product SupplyThis subcontract for the Department of Veterans Affairs National CMOP Office involves the supply of pharmaceutical products to prime contractors. The agreement mandates that all products feature distinct 11-digit NDCs and maintain expiration dates of more than 12 months from the date of delivery. To maintain quality control, shipments are limited to a maximum of three lot numbers and must include 100cc bottles with child safety caps and unit-of-use packaging. The supplier is required to provide OEM documentation and strictly adhere to regulations regarding Counterfeit Items and Gray Market products. All deliveries must be accompanied by appropriate packing slips. Performance for this contract takes place in Ladson, South Carolina, under NAICS code 325412.

National Cmop Office (36C770)

POSTED

DEADLINE

6505--766-27-1-400-0021 -Charleston CMOP CALCIUM 500MG/VIT D 500UNIT CHEW TAB 90CT -(VA-27-00014312)

Solicitation # 36C77027Q0013

The Department of Veterans Affairs National CMOP Office is conducting market research through a Sources Sought notice to identify qualified sources for Calcium 500mg/Vitamin D 500unit chewable tablets in 90-count packaging. This effort is for market research purposes only and does not constitute a solicitation or an obligation to issue a contract. Interested vendors must submit their company point of contact, SAM Unique Entity ID, and a capability statement via email to the contract specialist by October 29, 2026. The anticipated requirement involves a total quantity of 3,200 packages, delivered in monthly increments of 800 units over four months, with the first delivery due 10 days after receipt of order. Products must be sourced directly from the Original Equipment Manufacturer and possess an FDA therapeutic equivalence code of A, unless all drugs in the family group are B rated. Technical requirements include a distinct eleven-digit National Drug Code for each product, a minimum shelf life of 12 months from delivery, and specific bottle dimensions of at least 100cc with a 5.75-inch circumference and child-safety caps for packages under 500 count. Strict packaging and labeling standards apply, requiring bar codes that conform to GS1-128 or HIBCC/HIBC standards with a minimum ANSI/ISO/IEC Quality Grade C. Bar codes must be placed on both the outside wrapper and the immediate container. Shipping documentation must include the VA Purchase Order and Obligation numbers, and products must be sorted by lot number, with only one lot per box. Invoicing will be handled by the VA Fiscal Service Center, and the invoice price must strictly match the purchase order price to avoid payment delays.

National Cmop Office (36C770)

POSTED

DEADLINE

Supply of Bupivacaine and Epinephrine InjectionThis subcontract involves the supply of Bupivacaine HCl and Epinephrine pharmaceutical anesthetic combinations for prime contractors supporting Department of Defense medical supply contracts. The requirement specifies 1.8 mL cartridges containing 0.500 PCT W/V Bupivacaine HCl and 0.005 mg Epinephrine/mL, packaged in sets of 50. The total delivery quantity is 1.000 CN of injection cartridges, which must adhere to NSN 6505-01-189-3973 and all applicable FDA manufacturing standards. Managed by the Medical Supply Chain Pharm FSA, the contract mandates a minimum shelf life of 15 months upon delivery. The performance location is designated as FPO 96675. Interested parties must respond by November 2, 2026, under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Dibucaine Ointment USP Formulation and ManufacturingThis subcontract involves the chemical formulation and manufacturing of Dibucaine Ointment USP for prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain. The scope of work requires blending USP-grade Dibucaine and ointment base to a 1% concentration in accordance with USP standards. To ensure a 36-month shelf life, the provider must maintain strict quality control and temperature-controlled storage between 15 and 30 degrees Celsius for the bulk delivery of the product. Compliance requirements for this contract include mandatory FDA registration and adherence to the Buy American Act and the Berry Amendment. The performance of these services is centered in Fort Stewart, Georgia, under NAICS code 325412. Interested parties must respond by November 2, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Pressure Sensitive Adhesive Tape (NSN 7510-01-679-4381)This subcontract involves the supply of pressure sensitive adhesive tape, identified by NSN 7510-01-679-4381, to prime contractors supporting Department of Defense supply contracts. The vendor is required to deliver a physical quantity of 2,000 rolls of tape that strictly adhere to the DLA Master List of Technical and Quality Requirements, specifically requirement RA001, and all other specifications associated with the provided National Stock Number. The contract is managed under NAICS code 325412 for the agency Construction and Equipment T & IFO EQ. Performance of the contract will take place in Cherry Point, zip code 28533-8051. The solicitation was posted on October 25, 2026, with a response deadline set for November 5, 2026.

CONSTRUCTION & EQUIPMENT T & IFO EQ

POSTED

3 days ago

DEADLINE

in 8 days

AI Contract Overview

Contract SPE2DP-26-T-4947 is a solicitation issued by the Department of Defense Medical Supply Chain Pharm FSA for the procurement of Guaifenesin and Dextromethorphan Hydrobromide extended-release bi-layer tablets. Each unit consists of a bottle containing 30 individually sealed tablets, with each tablet containing 600 milligrams of Guaifenesin and 30 milligrams of Dextromethorphan HBr for a 12-hour duration. The total quantity requested is 8 packages, with a required delivery date of July 2, 2025, and a delivery window of 20 days after order. The product is FDA regulated and must be stored at 20-25 degrees Celsius. It has a total shelf life of 36 months, with a minimum of 31 months remaining upon receipt by the government. Packaging must comply with DLA packaging requirements and Medical Marking Standard No. 1, including specific labeling for the National Stock Number 6505-01-599-7666, manufacturer, lot number, and expiration date. Delivery is FOB Destination to the 5th BN 14th Marines in Seal Beach, California, and must be shipped via traceable means.

General Info

DoD procurement of 8 packages of Guaifenesin/Dextromethorphan tablets by July 2, 2025.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

800 SEAL BEACH BLVD BLDG 14 NSW, SEAL BEACH, CA, 90740-5607, USA

Set-Aside

NONE

Documents

SPE2DP-26-T-4947 Request for Quotations

rfq

High

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedSep 8

Solicitation

Response DeadlineSep 14

Deadline has passed

Submission Closed

09/14/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUSA

Contacts

Timothy Mccauley

contact@example.gov

+1 (555) 000-0000

Full Description

GUAIFENESIN AND DEX
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
EXTENDED-RELEASE TABLETS
.
MAIN INGREDIENTS INCLUDES 600 MILLIGRAMS
OF GUAIFENESIN (EXPECTORANT), AND:
30 MILLIGRAMS OF DEXTROMETHORPHAN HBR
EXTENDED-RELEASE BI-LAYER TABLETS
(COUGH SUPPRESSANT)
.
12 HOUR DURATION, EXPECTORANT & COUGH
SUPPRESSANT
.
UNIT OF ISSUE IS A BOTTLE CONTAINING
30 INDIVIDUALLY SEALED EXTENDED-RELEASE
BI-LAYER TABLETS
.
TOTAL SHELF LIFE IS 36 MONTHS.
.
THERE SHALL BE A MINIMUM OF 31 MONTHS
OF REMAINING SHELF LIFE AT THE TIME
OF RECEIPT BY THE FIRST GOVERNMENT ACTIVITY
.
STORE AT 20-25°C (68-77°F)
.
LABELING AND MARKING:
MUST INCLUDE:
NATIONAL STOCK NUMBER
MANUFACTURER
DATE OF MANUFACTURER, EXPIRATION DATE
OR RETEST DATE
CONTRACT NUMBER
LOT NUMBER
.
1/14/2015
.
1 PG = 40 TT
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
SPE2DP-26-T-4947
SECTION B
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RECKITT BENCKISER LLC 0MWS8 P/N NDC63824-0056-34
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018205108 0001 PG 8.000
NSN/MATERIAL:6505015997666
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
SPE2DP-26-T-4947
SECTION B
PR: 7018205108 PRLI: 0001 CONT’D
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
M14640
COMMANDING OFFICER
5TH BN 14TH MARINES 4MARDIV MFR
800 SEAL BEACH BLVD BLDG 14 NSW
SEAL BEACH CA 90740-5607
US
SHIP BY TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
M14640
SUPO M14640 T: +1 (555) 000-0000
5TH BN 14TH MARINES 4MARDIV MFR
800 SEAL BEACH BLVD BLDG 14 NSW
SEAL BEACH CA 90740-5607
US
M/F: (TCN) M1464051770056
RDD: 200
PROJ: TP 3
SUPP ADD: M14640 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 13
DIC: A3A DIST: ADV: 2A FC: CV
Need Ship Date:00/00/0000 Original Required Delivery Date:07/02/2025
SPE2DP-26-T-4947 NSN/Part Number: 6505-01-599-7666 Quantity: 8 PG Purchase Request: 7018205108QTY: 8 Delivery: 20 days ADO